| __timestamp | BioCryst Pharmaceuticals, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 13608000 | 1288519000 |
| Thursday, January 1, 2015 | 48257000 | 1465761000 |
| Friday, January 1, 2016 | 26353000 | 1598800000 |
| Sunday, January 1, 2017 | 25186000 | 1725300000 |
| Monday, January 1, 2018 | 20653000 | 1627800000 |
| Tuesday, January 1, 2019 | 48835000 | 1448800000 |
| Wednesday, January 1, 2020 | 17812000 | 1483300000 |
| Friday, January 1, 2021 | 157170000 | 1685500000 |
| Saturday, January 1, 2022 | 270827000 | 1936300000 |
| Sunday, January 1, 2023 | 331412000 | 2327500000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, revenue growth is a key indicator of success. Over the past decade, United Therapeutics Corporation has consistently outperformed BioCryst Pharmaceuticals, Inc. in annual revenue. From 2014 to 2023, United Therapeutics saw a remarkable increase of approximately 81% in revenue, peaking at $2.33 billion in 2023. In contrast, BioCryst's revenue, while growing, reached $331 million in the same year, marking a significant 23-fold increase from its 2014 figures.
This data highlights United Therapeutics' dominant market position, driven by its robust product pipeline and strategic market expansions. Meanwhile, BioCryst's impressive growth trajectory, despite being smaller, underscores its potential in niche markets. As the biotech industry continues to evolve, these companies exemplify different strategies for success, with United Therapeutics focusing on scale and BioCryst on innovation.
Revenue Insights: Pfizer Inc. and BioCryst Pharmaceuticals, Inc. Performance Compared
Revenue Insights: Zoetis Inc. and United Therapeutics Corporation Performance Compared
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Revenue Showdown: BeiGene, Ltd. vs BioCryst Pharmaceuticals, Inc.
Revenue Showdown: United Therapeutics Corporation vs Genmab A/S
Who Generates More Revenue? United Therapeutics Corporation or Exelixis, Inc.
Comparing Revenue Performance: United Therapeutics Corporation or Lantheus Holdings, Inc.?
United Therapeutics Corporation vs Cytokinetics, Incorporated: Examining Key Revenue Metrics
United Therapeutics Corporation and PTC Therapeutics, Inc.: A Comprehensive Revenue Analysis
United Therapeutics Corporation vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Breaking Down Revenue Trends: United Therapeutics Corporation vs Celldex Therapeutics, Inc.
Breaking Down Revenue Trends: BioCryst Pharmaceuticals, Inc. vs Evotec SE